While you are waiting, check out other recent reports in
CRB's Horizons series.
Life Sciences 2024
The fifth installment of our Horizons: Life Sciences series invites North American, European, and multinational companies to share their perspectives on biopharmaceutical research and manufacturing. Built on the insights of 500 industry professionals, this facility-focused report offers guidance to stay ahead in the rapidly evolving life sciences sector.
Market Conditions Q2 2025
Our Horizons: Market Conditions report is a quarterly snapshot of the construction economy that addresses the challenges of capital project planning. It covers supply chain, escalation, labor and more.